logo-loader

Horizon Discovery lands a share of £1.67m Biotech research grant

Last updated: 11:17 19 Feb 2015 GMT, First published: 12:17 19 Feb 2015 GMT

The CEO of AIM listed Biotech research group Horizon Discovery (LON:HZD) tells Proactiveinvestors about their latest joint venture Genomics project. Darrin Disley is confident that their research into the development of new tools using chinese hamster ovarian cell lines, will create  a new generation of hi value biopharmaceuticals.

Acquisition gives Horizon Discovery a 'full and complete suite of tools' to...

Chris Claxton, VP Investor Relations & Corporate Communications at Horizon Discovery Group PLC (LON:HZD), discusses with Proactive their 'transformational' acquisition of GE healthcare business Dharmacon. The US$85mln deal was announced in July and funded through cash and shares and...

on 4/9/17